Drug granted conditional approval to treat CLL in CanadaOctober 6, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Medicare doesn’t lower TKI costs enough, study suggestsOctober 4, 2016Leukemia, Myelodysplasia, TransplantationPharmacyCML
Ponatinib approved to treat CML, ALL in JapanSeptember 30, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
EMA says plasma/urine-derived meds are safe from ZikaSeptember 22, 2016ThrombosisBlood BankingPharmacyRelated Issues
Drug granted fast track designation for MFSeptember 14, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA grants drug orphan designation for PNHSeptember 13, 2016AnemiaThrombosisPharmacyBleeding Disorders
FDA expands approval of blinatumomabSeptember 2, 2016Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
FDA approves new indication for ofatumumab in CLLSeptember 1, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyRelated IssuesNon-Hodgkin Lymphoma
NICE approves bosutinib for routine NHS useAugust 26, 2016Leukemia, Myelodysplasia, TransplantationPharmacyCML